Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „trastuzumab“
Suchtreffer
Begriffe & Kennungen
Herwenda · 4.5 · Effect of trastuzumab on the pharmacokinetics of other antineoplastic agents
Eintrag öffnenHerwenda · 4.5 · The administration of concomitant anastrozole did not appear to influence the pharmacokinetics of trastuzumab.
Eintrag öffnenHerwenda · 4.8 · Amongst the most serious and/or common adverse reactions reported in trastuzumab usage (intravenous and subcut
Eintrag öffnenHerwenda · 4.8 · In 3 pivotal clinical studies of adjuvant trastuzumab given in combination with chemotherapy, the incidence of
Eintrag öffnenHerwenda · 4.8 · In the pivotal metastatic studies of intravenous trastuzumab, the incidence of cardiac dysfunction varied betw
Eintrag öffnenHerwenda · 4.8 · It is estimated that approximately 40% of patients who are treated with trastuzumab will experience some form
Eintrag öffnenHerwenda · 4.8 · Severe pulmonary adverse reactions occur in association with the use of trastuzumab and have been associated w
Eintrag öffnenHerwenda · 4.8 · Table 1 Undesirable effects reported with intravenous trastuzumab monotherapy or in combination with chemother
Eintrag öffnenHerwenda · 4.8 · The clinical relevance of these antibodies is not known. The presence of anti-trastuzumab antibodies had no im
Eintrag öffnenHerwenda · 4.8 · There are no immunogenicity data available for trastuzumab in gastric cancer.
Eintrag öffnenHerwenda · 4.8 · When trastuzumab was administered after completion of adjuvant chemotherapy NYHA class III-IV heart failure wa
Eintrag öffnenKadcyla · 4.5 · In vitro metabolism studies in human liver microsomes suggest that DM1, a component of trastuzumab emtansine,
Eintrag öffnenKadcyla · 4.8 · 11 Table 3 Tabulated list of ADRs in patients treated with trastuzumab emtansine in clinical studies System Or
Eintrag öffnenKadcyla · 4.8 · Extravasation Reactions secondary to extravasation have been observed in clinical studies with trastuzumab emt
Eintrag öffnenKadcyla · 4.8 · Haemorrhage Haemorrhagic events were reported in 34.8% of patients in MBC clinical studies with trastuzumab em
Eintrag öffnenKadcyla · 4.8 · Immunogenicity As with all therapeutic proteins, there is the potential for an immune response to trastuzumab
Eintrag öffnenKadcyla · 4.8 · Table 4 Laboratory abnormalities observed in patients treated with trastuzumab emtansine in study TDM4370g/BO2
Eintrag öffnenKadcyla · 4.8 · Table 5 Laboratory abnormalities observed in patients treated with trastuzumab emtansine in study BO27938/KATH
Eintrag öffnenKadcyla · 4.8 · Tables 4 and 5 displays laboratory abnormalities observed in patients treated with trastuzumab emtansine in cl
Eintrag öffnenKadcyla · 4.8 · The ADRs in 2 611 patients treated with trastuzumab emtansine are presented in Table 3. The ADRs are listed be
Eintrag öffnen